Altuviiio is an injectable medicine used to control and reduce the number of bleeding episodes in people with hemophilia A (congenital Factor VIII deficiency).
Lilly also will automatically cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance using Lilly insulin.